EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas

BACKGROUND. Non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) mutations have mixed responses to tyrosine kinase inhibitors (TKIs). Intertumor heterogeneity in EGFR mutations is one potential explanation for this phenomenon. METHODS. We performed direct sequencing to id...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chen, Zhi-Yong, Zhong, Wen-Zhao, Zhang, Xu-Chao, Su, Jian, Yang, Xue-Ning, Chen, Zhi-Hong, Yang, Jin-Ji, Zhou, Qing, Yan, Hong-Hong, An, She-Juan, Chen, Hua-Jun, Jiang, Ben-Yuan, Mok, Tony S., Wu, Yi-Long
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2012
Schlagworte:
Lung Cancer
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3399655/
https://ncbi.nlm.nih.gov/pubmed/22673630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0385
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge